Pediatric Neurology
Autism Spectrum Disorder
Regenerative medicine approaches for children with Autism Spectrum Disorder, designed to reduce neuroinflammation and support communication, behavior, and social development.
Autism Spectrum Disorder (ASD) is increasingly understood to involve neuroinflammation, immune dysregulation, and altered neural connectivity. Our pediatric regenerative program uses Wharton's jelly-derived mesenchymal stem cells (MSCs) and exosomes to target these biological mechanisms. The goal is to support the child's existing therapy plan by reducing inflammation and promoting a healthier environment for neural development. Every child is evaluated by a pediatric specialist and a multidisciplinary team before treatment.
What patients experience
- May reduce neuroinflammation associated with ASD
- Supports communication, social interaction, and behavior goals
- Personalized pediatric protocols with child-friendly care coordination
- GMP-certified laboratory production with rigorous quality controls
- Integrated with existing ABA, speech, and occupational therapy
- Family-centered follow-up and developmental monitoring
Treatment protocol
The program begins with a comprehensive pediatric evaluation including medical history, developmental assessment, and baseline laboratory testing. Treatment is administered in a calm, pediatric-appropriate setting under specialist supervision. Families receive detailed pre- and post-treatment guidance, and follow-up visits monitor developmental milestones, behavior, and quality of life. We work closely with the child's existing therapists to align the regenerative approach with their broader care plan.
Free consultation
Talk to our medical team about your case
Get a personalized treatment plan and transparent pricing within 24 hours.